Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009
20 Julio 2009 - 10:10AM
PR Newswire (US)
Dedicated UPLC/MS System Solutions Taking on Increased Challenges
in Laboratories for Therapeutic Drug Monitoring, Disease
Management, Endocrinology, and Toxicology CHICAGO, July 20
/PRNewswire-FirstCall/ -- At this year's American Association for
Clinical Chemistry (AACC) meeting, Waters Corporation (NYSE: WAT)
is introducing clinical scientists to its expanded portfolio of new
products for clinical and research laboratories including a new
research use only (RUO) kit for quantitative measurement of
Tacrolimus, Sirolimus, Everolimus, and Cyclosporin A. A highlight
of the AACC meeting, the Waters MassTrak(TM) Immunosuppressants XE
RUO Kit provides laboratories an alternative to immunoassay test
kits for research laboratory analyses. This and other Waters system
platform solutions for amino acid analysis and for vitamin D
clinical research laboratories are on display at the AACC Annual
Meeting and Clinical Lab Expo, July 19 - 23 in Chicago. The
MassTrak Immunosuppressants XE RUO Kit is for clinical research
laboratories seeking an alternative to immunoassay kits for
quantitative measurement of immunosuppressant drug levels. Each kit
includes reagents, controls, and calibrators, a tuning mixture for
the mass spectrometer, and an analytical column for performing up
to 500 determinations /kit. Used with Waters ACQUITY TQD System,
the MassTrak Immunosuppressants XE RUO Kit achieves high
specificity in measuring the target analyte in the presence of drug
metabolites and addresses some of the analytical weaknesses of
immunoassay immunosuppressant drug measurement. The new MassTrak
Immunosuppressants XE RUO Kit is one of several innovative
applications for LC/MS/MS that Waters is spotlighting at AACC 2009.
Vitamin D Analysis Vitamin D deficiency has been associated with an
increased risk of osteoporosis, heart disease, diabetes and other
maladies. In the United States testing for vitamin D has increased
by 80-90 percent since 2007. For the first time at AACC, Waters
will exhibit a system platform optimized for 25-Hydroxyvitamin D
analysis for clinical research laboratories. This analytical system
and methodology features a robotic liquid handling system and
Waters ACQUITY TQD System for high-throughput measurement of total
25-Hydroxyvitamin as well as 25-Hydroxyvitamin D2 and D3. The test
method features a solid-phase extraction sample preparation step
that minimizes solvent usage, enhances automation, eliminates the
need for solvent evaporation and sample reconstitution. Further
information on the new method is included in a new product handout
available online from Waters (Part No. 720003044EN). Amino Acid
Analysis Over the past 50 years, amino acid analysis has come to be
recognized as a cornerstone in the nutritional and metabolic
research laboratory. At AACC, Waters is featuring its MassTrak
Amino Acid Analysis Solution, a comprehensive approach to the full
profile analysis of physiological amino acids in urine and plasma
in a research environment. This solution incorporates a Waters
ACQUITY UPLC system with pre-packaged, fully tested reagents and
consumables, pre-defined analytical, processing and reporting
methods and dedicated support, training and installation services
from Waters for the fastest possible start-up and continued
productivity in the clinical research laboratory. Clinical
Toxicology LC/MS/MS is now widely used in confirmation analysis in
clinical toxicology. The sensitivity, speed, selectivity and simple
sample pre-treatment requirements have led to LC/MS/MS methods
being adopted as the preferred choice for many important
applications. At AACC, Waters will exhibit its ACQUITY UPLC system
and tandem mass spectrometry products for this fast-growing
application area. In connection with this area of clinical
analysis, Waters has posted two video testimonials featuring CEO
Dr. Frank Fornari of Dominion Diagnostics of North Kingstown, Rhode
Island (USA) discussing his firm's ability to provide additional
expert services in the area of pain management and Dr. Michael
Evans of AIT Laboratories, Indianapolis, Indiana (USA) discussing
his laboratory's applications for Waters LC/MS/MS products in the
area of pain management and forensic toxicology. For Further
Information Waters is sponsoring an industry workshop on Wednesday,
July 22, 6 - 7:30 p.m. at the Fairmont Chicago Millennium Park
Hotel at 200 North Columbus Drive in the Moulin Rouge Room. This
workshop will feature several prominent industry scientists
speaking about their applications for LC/MS/MS in the areas of
vitamin D analysis and drugs of abuse testing. For more information
on this workshop, LC/MS/MS poster presentations, and Waters
products at AACC, go here. LC/MS/MS for the Clinical Laboratory
LC/MS/MS is now finding a role in the routine clinical laboratory,
with many laboratories using the technique for a variety of testing
including toxicology, therapeutic drug monitoring and
endocrinology. Improvements in assay performance, usability,
reliability and software capabilities are key drivers for its
adoption. Waters introduction of innovative system platforms,
standardized methods and reagents to support these solution
requirements are enabling more laboratories to adopt this powerful
analytical approach. In 2007, Waters received clearance from the
U.S. Food and Drug Administration (FDA) for a first-of-its-kind
commercially available kit specifically designed to quantify the
immunosuppressant tacrolimus in kidney and liver transplant
patients by LC/MS/MS. About Waters Corporation
(http://www.waters.com/) Waters Corporation creates business
advantage for laboratory-dependent organizations by delivering
practical and sustainable innovation to enable significant
advancements in such areas as healthcare delivery, environmental
management, food safety, and water quality worldwide. Pioneering a
connected portfolio of separations science, laboratory information
management, mass spectrometry and thermal analysis, Waters
technology breakthroughs and laboratory solutions provide an
enduring platform for customer success. With revenue of $1.58
billion in 2008 and 5,000 employees, Waters is driving scientific
discovery and operational excellence for customers worldwide.
Waters, MassTrak, ACQUITY, ACQUITY UPLC, UltraPerformance LC, and
UPLC are trademarks of Waters Corporation. DATASOURCE: Waters
Corporation CONTACT: Brian J. Murphy of Waters Corporation,
+1-508-482-2614, Web Site: http://www.waters.com/
Copyright